ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,263.20
      -1.69%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      80.745
      0.16%
      Bitcoin
      94,147.99
      -0.36%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Denali Capital Acquisition Corporation (DECA) Quote

      Denali Capital Acquisition Corporation

      Denali Capital Acquisition Corporation (DECA)

      NASDAQ
      11.97
      0.07
      (0.59%)
      Closed January 13 4:00PM
      Delayed by 15 minutes
      11.97
      0.00
      (0.00%)
      After Hours: 4:07PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      11.97
      Bid
      10.06
      Ask
      19.20
      Volume
      446
      11.90 Day's Range 12.00
      4.05 52 Week Range 12.25
      Market Cap
      60.423M
      Previous Close
      11.90
      Open
      11.90
      Last Trade
      1
      @
      11.84
      Last Trade Time
      Financial Volume
      $ 5,345
      VWAP
      11.985
      Average Volume (3m)
      2,908
      Shares Outstanding
      5,047,829
      Dividend Yield
      -
      PE Ratio
      95.45
      Earnings Per Share (EPS)
      0.13
      Revenue
      -
      Net Profit
      633k

      About Denali Capital Acquisition Corporation

      Denali Capital Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Denali Capital Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

      Sector
      Blank Checks
      Industry
      Blank Checks
      Headquarters
      Grand Cayman, Cym
      Founded
      -
      Denali Capital Acquisition Corporation is listed in the Blank Checks sector of the NASDAQ with ticker DECA. The last closing price for Denali Capital Acquisition was $11.90. Over the last year, Denali Capital Acquisition shares have traded in a share price range of $ 4.05 to $ 12.25.

      Denali Capital Acquisition currently has 5,047,829 shares outstanding. The market capitalization of Denali Capital Acquisition is $60.07 million. Denali Capital Acquisition has a price to earnings ratio (PE ratio) of 95.45.

      Ask ADVFN Intelligence (AI)

      DECA Latest News

      More News

      Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

      NEW YORK, NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...

      January 08 2025
      GlobeNewswire Inc.

      Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

      NEW YORK, NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...

      December 11 2024
      GlobeNewswire Inc.

      Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

      NEW YORK, NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...

      November 11 2024
      GlobeNewswire Inc.

      Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously

      As previously announced, Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA, the “SPAC”) entered into...

      November 06 2024
      GlobeNewswire Inc.

      Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary

      Scilex notified NASDAQ on October 28, 2024 that it has set a record date of November 7, 2024 (the “Record Date”) for the dividend of Scilex preferred stock to Scilex’s stockholders and certain...

      October 28 2024
      GlobeNewswire Inc.

      Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur a

      Semnur is currently in discussions regarding strategic regional and/or worldwide collaborations and potential outright acquisition of SP-102. Any such transactions may have the potential to...

      October 16 2024
      GlobeNewswire Inc.

      Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

      NEW YORK, NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) --  Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...

      October 11 2024
      GlobeNewswire Inc.

      Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

      NEW YORK, NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) --  Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account...

      September 11 2024
      GlobeNewswire Inc.

      Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination

      Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. (Nasdaq: DECA, the “SPAC”) announce the...

      September 03 2024
      GlobeNewswire Inc.

      Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

      NEW YORK, NEW YORK, , Aug. 09, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account...

      August 09 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.090.75757575757611.8811.9911.88191711.89763563CS
      40.110.92748735244511.8611.9911.81560211.88850957CS
      120.463.9965247610811.5112.2511.34290811.79892847CS
      260.655.7420494699611.3212.2511.3284211.62470442CS
      525.2277.33333333336.7512.254.05175638.12254696CS
      1562.0220.30150753779.9514.14.05234889.91211965CS
      2602.0220.30150753779.9514.14.05234889.91211965CS

      DECA - Frequently Asked Questions (FAQ)

      What is the current Denali Capital Acquisition share price?
      The current share price of Denali Capital Acquisition is $ 11.97
      How many Denali Capital Acquisition shares are in issue?
      Denali Capital Acquisition has 5,047,829 shares in issue
      What is the market cap of Denali Capital Acquisition?
      The market capitalisation of Denali Capital Acquisition is USD 60.07M
      What is the 1 year trading range for Denali Capital Acquisition share price?
      Denali Capital Acquisition has traded in the range of $ 4.05 to $ 12.25 during the past year
      What is the PE ratio of Denali Capital Acquisition?
      The price to earnings ratio of Denali Capital Acquisition is 95.45
      What is the reporting currency for Denali Capital Acquisition?
      Denali Capital Acquisition reports financial results in USD
      What is the latest annual profit for Denali Capital Acquisition?
      The latest annual profit of Denali Capital Acquisition is USD 633k
      What is the registered address of Denali Capital Acquisition?
      The registered address for Denali Capital Acquisition is MAPLES CORPORATE SERVICES LIMITED, PO BOX 309, UGLAND HOUSE, GRAND CAYMAN, KY1-1104
      Which industry sector does Denali Capital Acquisition operate in?
      Denali Capital Acquisition operates in the BLANK CHECKS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      VRMEVerifyMe Inc
      $ 2.57
      (52.98%)
      		57.83M
      WKEYWISeKey International Holdings AG
      $ 10.041
      (52.83%)
      		6.72M
      DATSDatChat Inc
      $ 4.8105
      (49.86%)
      		158.65M
      CDTConduit Pharmaceuticals Inc
      $ 0.1214
      (48.05%)
      		1.17B
      INTZIntrusion Inc
      $ 2.8888
      (44.44%)
      		40.61M
      IGMSIGM Biosciences Inc
      $ 2.095
      (-66.21%)
      		5.69M
      CDTGCDT Environmental Technology Investment Holdings Ltd
      $ 1.87
      (-51.30%)
      		2.28M
      MODVModivCare Inc
      $ 6.51
      (-47.88%)
      		2.73M
      AIFUAIX Inc
      $ 0.420501
      (-47.76%)
      		7.83M
      MRSNMersana Therapeutics Inc
      $ 0.691
      (-46.85%)
      		58.31M
      CDTConduit Pharmaceuticals Inc
      $ 0.1214
      (48.05%)
      		1.17B
      NVDANVIDIA Corporation
      $ 135.91
      (-3.00%)
      		207.53M
      RGTIRigetti Computing Inc
      $ 8.9299
      (-11.06%)
      		178.82M
      VMARVision Marine Technologies Inc
      $ 2.14
      (40.79%)
      		175.57M
      DATSDatChat Inc
      $ 4.8105
      (49.86%)
      		158.65M

      Discussion

      View Full Feed
      Steady_T Steady_T 2 minutes ago
      That sounds pretty optimistic to me. I'd think that the RA would like to see some data on other cancers before such a broad scope label.
      NWBO
      boi568 boi568 4 minutes ago
      I think he edited the question he asked to make it look neutral.
      AVXL
      Louinjaxxx Louinjaxxx 4 minutes ago
      So the extra 5 to 6 million shares will help you pay the taxes on you gain?  That makes sense.
      AXXA
      sunspotter sunspotter 11 minutes ago
      Dr. Jamil should know that once it is established that the primary endpoint has not been reached, it is widely recognised that it is not valid statistically to declare secondary endpoints and other sub-analyses as having reached statistical significance.

      It’s a (not very) sophisticat
      GALT
      nowwhat2 nowwhat2 17 minutes ago
      The Overhead Trendline, The 2.50 Level, The Overall Crypto Sector......

      Boy.......what ppl steer clear of considering here is a real mindblower.......


      https://investorshub.advfn.com/uimage/uploads/2025/1/13/rmobiXRP_!_12_45d_6pm_GLITCH_OHTL_250_SUMMARY.jpg
      XRPUSD
      PickStocks PickStocks 19 minutes ago
      You contradict yourself......" style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: Nunito, serif; background-color: rgba(255, 255, 255, 1); font-size: 1em"IF YOU owned P's, K's, or uq's ? ... the DTC Knows It' ... and, the DTC Knows EXACTLY How Many P's, K's, or uq's ... YO
      COOP
      Malolo Malolo 20 minutes ago
      Hello, I'm a newbie at AIM. Wondering if someone could recommend or provide a good spreadsheet?
      roncderu@gmail.com.
      OPennyS OPennyS 23 minutes ago
      If the predictions are correct it is going to be an interesting week.
      VXX
      Hoghead7 Hoghead7 26 minutes ago
      PORTHOS still on schedule. Seems like spring/summer commissioning
      https://www.linkedin.com/posts/porthos-co2_porthos-porthosco-co2-activity-7282763014376677376-qnb-?utm_source=share&utm_medium=member_android

      https://www.linkedin.com/posts/activity-7275803191202447360-EX6x?utm
      FCEL
      mining hound mining hound 34 minutes ago
      Hi all, thanks for happy new year wishes and I wish the same for all here too!
      HLLXF
      gfp927z gfp927z 43 minutes ago
      >>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
      ABT
      gfp927z gfp927z 44 minutes ago
      >>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
      ABT
      georgebailey georgebailey 44 minutes ago
      Steady I think the rubber hits the road when we see the MHRA label assignment on L. Based on safety, phase 3 and RWE we just might see a broad scope label which I’ll call a home run.
      NWBO
      Birdbrain Ideas Birdbrain Ideas 45 minutes ago
      If what you suggest is a possibility, I would view the early December "Investor's Day" in hindsight as more of a dog and pony show for potential buyers. At this point, investors have been beaten to the point that most of us would accept if the company was sold for $6 or $7 a share. What would that b
      AMRN
      devil dog 96 devil dog 96 47 minutes ago
      In October of 2023 The best setup in the OTC challenge was posted and ATMH still holds the #1 spot! Not one ticker has been found with a better setup! 🏆️

      If anyone wants to take the challenge and prove me wrong here is the link https://investorshub.advfn.com/b
      ATMH
      3jack 3jack 47 minutes ago
      We will persevere!
      AVXL
      gfp927z gfp927z 48 minutes ago
      >>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
      ISRG
      3jack 3jack 48 minutes ago
      We know who you are!
      AVXL
      gfp927z gfp927z 48 minutes ago
      >>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
      ISRG
      Lazerator Lazerator 51 minutes ago
      Not "walking dead", just dead. I just wish they'd declare bankruptcy instead of pretending like it's going to trade again.
      Lazerator Lazerator 52 minutes ago
      Clearly, Port turned out to be the fool. Actually, he made fools of all you guys who bought into his scam.
      imho imho 53 minutes ago
      In the comment section of this article,
      https://seekingalpha.com/article/4748984-playing-the-odds-of-anavex-alzheimers-drug-approval#scroll_comments

      Someone named Stephen Ayers in his Saturday, 12:42PM comment, says

      I asked ChatGPT why the following statement, w
      AVXL
      Ryoko Ryoko 53 minutes ago
      It's not going to be audited. They lied again. They do that once a year. Been that way for the last 4 years.
      IBGR
      axelvento axelvento 56 minutes ago
      has announced that it will be paying its dividend of $0.43 on the 7th of March, an increased payment from last year's comparable dividend. This makes the dividend yield 6.5%, which is above the industry average

      $PFE
      PFE

      Your Recent History

      NASDAQ
      DECA
      Denali Capital Acquisition
      BIT
      UB4Q61
      Unicredit Bank
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads